-
1 Comment
ECO Animal Health Group plc is currently in a long term uptrend where the price is trading 16.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.6.
ECO Animal Health Group plc's total revenue sank by 0.0% to $14M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $509K since the same quarter in the previous year.
Finally, its free cash flow grew by 388.0% to $2M since the same quarter in the previous year.
Based on the above factors, ECO Animal Health Group plc gets an overall score of 3/5.
CurrencyCode | GBP |
---|---|
ISIN | GB0032036807 |
Exchange | LSE |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 41M |
---|---|
PE Ratio | 60.0 |
Target Price | 163.625 |
Beta | 0.03 |
Dividend Yield | None |
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EAH.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025